| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3616 |
| Trial ID | NCT06079164 |
| Disease | Large B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | KITE-197 |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | A Phase 1 Open-label, Single Arm, Multicenter Study Evaluating the Safety and Efficacy of KITE-197 in Subjects With Relapsed or Refractory Large B-cell Lymphoma |
| Year | 2023 |
| Country | Australia|Canada|United States |
| Company sponsor | Kite, A Gilead Company |
| Other ID(s) | KT-US-656-0601 |
| Cohort 1 | |||||||||||
|
|||||||||||